Company intelligence / Profile preview

SHL Telemedicine

Tel Aviv, Tel Aviv District, Israelshl-telemedicine.com ↗

Ownership: Public · SHLT
Employees: ~583
Development stage: Commercial

Overview

SHL Telemedicine has over a quarter-century of experience providing commercialized telemedicine solutions for cardiovascular and chronic disease management. Its services are used by over one million users globally. Clinical results include improved survival rates post-heart attack, reduced hospitalizations/readmissions for cardiac patients, and enhanced quality of life through early detection/intervention enabled by continuous remote monitoring.

Therapeutic areas: OtherPulmonologyCardiovascular
Modalities: DeviceNon-pharmacological therapyDigital health platform (telemonitoring)
Industry: Non-Academic Healthcare

Partnerships

Health insurance companieshospitalsclinicsphysicians

Financials

Market cap: $33.6M
Total revenue: $28.9M
Enterprise value: $32.2M

Beyond the preview

Go deeper on SHL Telemedicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHL Telemedicine.

Explore the full profile